home All News open_in_new Full Article

Predictmedix AI Screening Technology Emerges as Strategic Asset Amid FDA’s Regulatory Shift Away from Animal Testing

TORONTO — Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider in AI-driven health and safety solutions, welcomes the U.S. Food and Drug Administration’s (FDA) groundbreaking move to phase out mandatory animal testing in drug development. As the pharmaceutical and biotech industries pivot toward more ethical and technologically […]


today 3 d. ago attach_file Other

attach_file Events
attach_file Other
attach_file Culture
attach_file Technology
attach_file Politics
attach_file Sport


ID: 4268396737
Add Watch Country

arrow_drop_down